1 year return (CAGR)
-47.41%
Telomir Pharmaceuticals, Inc. Common Stock Exchange (NASDAQ, USD)
TELO
1.25
-0.02 (-1.49%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
90.78M
Price/Sales
-
Ent value
84.92M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.34 |
| Daily high | 1.34 |
| Daily low | 1.30 |
| Daily Volume | 83K |
| All-time high | 11.90 |
| 1y analyst estimate | 15.50 |
| Beta | -0.24 |
| EPS (TTM) | -0.17 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 12 May 2026 |
Downside potential
Loading...
Downside potential data
| TELO | S&P500 | |
| Current price drop from All-time high | -89.50% | -0.58% |
| Highest price drop | -90.92% | -56.47% |
| Date of highest drop | 12 Feb 2026 | 9 Mar 2009 |
| Avg drop from high | -70.09% | -10.68% |
| Avg time to new high | 141 days | 12 days |
| Max time to new high | 559 days | 1805 days |
News
